Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1,091,129,524
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
52,143,835
-
Shares change
-
+3,758,992
-
Total reported value, excl. options
-
$7,056,266,230
-
Value change
-
+$525,905,376
-
Put/Call ratio
-
52%
-
Number of buys
-
120
-
Number of sells
-
-58
-
Price
-
$135.34
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q4 2020
212 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q4 2020.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52,143,835 shares
of 1,091,129,524 outstanding shares and own 4.8% of the company stock.
Largest 10 shareholders include Capital World Investors (8,551,442 shares), FMR LLC (4,926,748 shares), BAILLIE GIFFORD & CO (3,850,149 shares), BlackRock Inc. (3,584,247 shares), BRILLIANCE ASSET MANAGEMENT Ltd (3,046,976 shares), VANGUARD GROUP INC (2,366,873 shares), WELLINGTON MANAGEMENT GROUP LLP (2,315,020 shares), BAMCO INC /NY/ (2,046,155 shares), FEDERATED HERMES, INC. (1,990,860 shares), and CREDIT SUISSE AG/ (1,489,358 shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.